AW
FBT icon

ACG Wealth’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

ACG Wealth’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,609
Closed -$604K – 284
2020
Q1 		$604K Sell
4,609
-35
-0.8% -$4.99K 0.11% 164
2019
Q4 		$691K Buy
+4,644
New +$638K 0.1% 169

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

ACG Wealth's FBT Position: Q2 2020 in Review

ACG Wealth sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2020, closing a stake of 4,609 shares — an estimated $604K sold.

ACG Wealth first reported a position in FBT in Q4 2019 and held it in 2 quarters. The position peaked at $691K in Q4 2019. 224 funds tracked by Wall St. Rank hold FBT as of Q2 2020.

  • ACG Wealth reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2020 after selling out during the quarter.
  • ACG Wealth sold 4,609 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2020, an estimated $604K.
  • ACG Wealth first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and held it in 2 quarters.
  • ACG Wealth's First Trust NYSE Arca Biotechnology Index Fund position peaked at $691K in Q4 2019.
  • 224 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2020.

Based on ACG Wealth's 13F filing for Q2 2020, filed 7 Oct 2020.